Sunshine Biopharma, Inc. (NASDAQ:SBFM) Sees Significant Increase in Short Interest

Sunshine Biopharma, Inc. (NASDAQ:SBFM) saw a significant growth in short interest during the month of October. As of October 31st, there was short interest totalling 374,100 shares, a growth of 16.4% from the October 15th total of 321,500 shares. Based on an average daily volume of 180,600 shares, the short-interest ratio is presently 2.1 days. Currently, 18.7% of the company’s stock are short sold.

Sunshine Biopharma Stock Down 8.8 %

Shares of SBFM stock traded down $0.22 during trading on Friday, reaching $2.35. The company’s stock had a trading volume of 311,442 shares, compared to its average volume of 128,355. Sunshine Biopharma has a one year low of $2.25 and a one year high of $637.20. The business has a fifty day moving average price of $2.92 and a 200-day moving average price of $1.72. The company has a market cap of $2.87 million, a price-to-earnings ratio of -0.02 and a beta of 1.38.

Sunshine Biopharma (NASDAQ:SBFM) last issued its quarterly earnings results on Tuesday, November 5th. The company reported ($0.94) EPS for the quarter, missing the consensus estimate of $9.00 by ($9.94). The business had revenue of $8.44 million for the quarter. Sunshine Biopharma had a negative return on equity of 17.89% and a negative net margin of 12.82%.

Sunshine Biopharma Company Profile

Sunshine Biopharma, Inc, a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products.